Research And Markets Research And Markets

India Pharmaceutical Industry Research and Forecast to 2016

  • ID: 2118783
  • April 2012
  • Region: India
  • 65 Pages
  • Ken Research Private Limited
1 of 4


  • Abbott India
  • Aurobindo pharmaceuticals
  • Cipla
  • DR. Reddy’s
  • GSK India
  • Lupin
  • MORE

The report titled “India Pharmaceutical Industry Research and Forecast to 2016” offer detailed analysis on the country’s bulk and formulations market which is sub-segmented into OTC, prescription drugs and generic drugs. It analyses major bio-pharmaceutical market segments, top therapeutic categories and traditional medicine market (herbal drugs, ayurvedic and homeopathy). Report also include SWOT analysis, major driving forces, industry growth barriers, Opportunities, Regulatory structure, Macro economy factors and Political environment of the country. Report also profile major players (domestic and international) and forecast industry and its segments’ growth.

Generic drugs have a dominant position in the rapidly expanding Indian pharmaceutical industry. India is among one of the largest bulk drugs exporters but represent only one fourth of the total pharmaceutical market while formulation drugs account for the three fourth shares. Domestic market has showcased resilience during the economic crisis and has recorded a steady growth. Rising aging population indicates compelling opportunity for drug manufacturers to focus on bone health, dietary supplements and dementia and other age related diseases. Direct marketing is in its development stage in the country while multi level marketing companies are trying hard to understand spending behavior of middle class population in India.

Urban areas accounted for 67% of the OTC demand even though a large Indian population resides in the rural areas which indicate a huge potential for further growth. READ MORE >

Note: Product cover images may vary from those shown
2 of 4


  • Abbott India
  • Aurobindo pharmaceuticals
  • Cipla
  • DR. Reddy’s
  • GSK India
  • Lupin
  • MORE

1. Indian Healthcare Industry

1.1. India Pharmaceutical Industry Snapshot

1.1. Market Size

1.2. Biopharmaceuticals and Classification


Diagnostics and therapeutics

1.3. India Pharmaceutical Market Forecast

2. India Pharmaceutical Market Segments

2.1. Bulk vs Formulation Drugs

3. Classification on the basis of API manufacturing segments

3.1. Generic Drugs

3.2. Over the Counter Drugs (OTC)

3.2.1. Top Therapeutic Categories Traditional Medicine Market Herbal Drugs Ayurvedic Medicine Homeopathy Medicine

4. Growth Drivers

5. Opportunities

5.1. Rising Demand for Vitamin and Dietary Supplements

5.2. Rising Diabetes cases and Medication Demand
5.3. Medical Tourism Benefiting Indian Pharmaceutical Industry

6. SWOT Analysis





7. Growth Barriers

8. Recent Pharmaceutical Industry M&A’s

9. Regulatory Structure


FDI Regulations

10. Country Analysis

10.1. Key Findings

10.2. Political Environment

10.3. Macro-Economic and Industry Indicators

10.3.1. GDP Enabling Growth of Pharmaceuticals

10.3.2. Import/Export

10.3.3. Growth Driven by Rising Population

11. Industry Competition and Domestic Players Profiling

11.1. Competitive Landscape

11.2. Domestic Vs International companies

12. Appendix

12.1. Abbreviations

12.2. Definitions

12.3. Research Methodology

Data Collection Methods


Variables (Independent)

Multi Factor Based Sensitivity Model (SPSS Analysis)

Final Conclusion

12.4. Disclaimer


Figure 1: Indian Pharmaceutical Industry Value Chain

Figure 2: India Pharmaceutical Industry Distribution Structure
Figure 3: India Pharmaceutical Industry by Value (2006-2011)

Figure 4: Domestic Pharmaceutical Market, Retail Sales by Value (2006-2011)

Figure 5: Bio-pharmaceuticals Market in India by Value (2006-2011)

Figure 6: Bio-pharmaceuticals Product Classification in % (2011)

Figure 7: Vaccine Demand in India by Value (2006-2011)

Figure 8: Domestic Pharmaceutical Market by value (2011-2016)

Figure 9: India Pharmaceutical Industry Forecast (2011-2016)

Figure 10: India Pharmaceutical Industry Segments in 2011
Figure 11: India Generic Drug Market Size by Value (2006-2011)

Figure 12: OTC Drugs Demand by Value (2006-2011)

Figure 13: OTC Product Demand by Categories in 2011

Figure 14: India Herbal Supplements Market by Value and Forecast (2006-2015F)

Figure 15: Healthcare Expenditure in India (2006-2015)

Figure 16: Indian Rural and Urban Population in Million, 2006-2015

Figure 17: Total R&D Expenditure of the Indian Pharmaceutical Industry (2006-2016)

Figure 18: Vitamin and Dietary Supplements Market by Value and Forecast (2006-2011E)
Figure 19: Number of Diabetic Patients in India in Million, FY’2006-2016
Figure 20: Number of Total Medical Tourists in Thousands and Medical Tourists Receipts in USD Million, 2006-2010

Figure 21: India’s GDP at Current Prices in USD Billion, 2006-2015

Figure 22: India’s Population in Million, 2006-2016


Table 1: Major Hospital Chains in India

Table 2: Ranking of Leading Bio-pharmaceutical Companies (2010-11)

Table 3: Diagnostics and Therapeutics Demand by Value (2009-2011)

Table 4: Number of Bulk and Formulations Manufacturing Units in India in 2010

Table 5: Pharma Special Economic Zone (SEZ) in Maharashtra

Table 6: Famous Medication for General Diseases

Table 7: India AYUSH products Export by Value (2006-2010)

Table 8: India Herbal Products Export by Value (2006-2009)

Table 9: Labor Participation Rates by Gender and by Age Group in India, 2000 and 2008

Table 10: Drugs and Pharmaceuticals FDI Equity Inflows (2009-2011)

Table 11: Cumulative FDI Inflow (Apr 2000-Feb 2011)

Table 12: Leading Companies R&D Expenses as a % of Sales (2008-2010)

Table 13: Recent M&A’s in Indian Pharmaceutical Industry, 2010-2011

Table 14: Regulatory Authorities and Guidelines

Table 16: India Economy (2010-2012)

Table 17: Export/Import Statistics (2006-2010)

Table 18: Drugs, Pharmaceuticals and Fine Chemical Exports in India, Monthly Statistics (2009 & 2010)

Table 19: Imports of Medicinal and Pharmaceutical Products (2006-2009)

Table 20: Income Distribution among Households in thousands in India, 2009-2012

Table 21: Leading Domestic Pharmaceutical Companies, Financials and Key Strategies

Table 22: Leading International Pharmaceutical Companies, Financials and Key Strategies

Table 23: Correlation Matrix of the India Pharmaceutical Industry

Table 24: Independent Variables

Table 25: Correlation Matrix of the India Pharmaceutical Industry

Note: Product cover images may vary from those shown
3 of 4

- Cipla
- Ranbaxy
- DR. Reddy’s
- Sun Pharma
- Lupin
- Aurobindo pharmaceuticals
- GSK India
- Abbott India
- Pfizer
- Novartis India

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown